Literature DB >> 9365118

Novel lymphocyte-specific CC chemokines and their receptors.

O Yoshie1, T Imai, H Nomiyama.   

Abstract

By using a cloning method termed the signal sequence trap as well as by searching for chemokine homologous sequences in the database of expressed sequence tags, cDNA fragments potentially encoding novel CC chemokines were initially identified. Using these sequences, we have cloned five novel human CC chemokines termed TARC, LARC, ELC, SLC, and PARC. These chemokines are constitutively expressed especially in some lymphoid tissues with individually unique expression patterns. The recombinant proteins are all found to be selectively chemotactic for lymphocytes but not for monocytes or neutrophils. Each chemokine appears to interact with a class of receptors on lymphocytes that is not shared by any other chemokines so far tested. Furthermore, we have identified CCR4 as the specific receptor for TARC, GPR-CY4/DRY6/CKR-L3/STRL22 as that for LARC (CCR6), and EBI1/BLR2 as that for ELC (CCR7). Only the gene for PARC is mapped to the traditional CC chemokine gene cluster at chromosome 17q11.2, whereas those for TARC, LARC, ELC, and SLC are localized at different loci. Collectively, these five CC chemokines may constitute a new category of CC chemokines that are involved in trafficking and homing of particular subsets of lymphocytes in particular lymphoid tissue microenvironments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365118     DOI: 10.1002/jlb.62.5.634

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  40 in total

Review 1.  Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system.

Authors:  O Yoshie
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Chemokine receptors and leukocyte trafficking in the mucosal immune system.

Authors:  Ifor R Williams
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.

Authors:  E S Choi; E M Pierce; C Jakubzick; K J Carpenter; S L Kunkel; H Evanoff; F J Martinez; K R Flaherty; B B Moore; G B Toews; T V Colby; E A Kazerooni; B H Gross; W D Travis; C M Hogaboam
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

4.  CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor.

Authors:  Wasim A Dar; Stuart J Knechtle
Journal:  Immunology       Date:  2007-01-22       Impact factor: 7.397

5.  Activated human Foxp3+ regulatory T cells produce membrane-bound TNF.

Authors:  Alexander Nelson; Christina Cunha; Michael I Nishimura; Makio Iwashima
Journal:  Cytokine       Date:  2018-06-06       Impact factor: 3.861

6.  Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Authors:  Melissa A Byers; Psachal A Calloway; Laurie Shannon; Heather D Cunningham; Sarah Smith; Fang Li; Brian C Fassold; Charlotte M Vines
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

7.  The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.

Authors:  L Trentin; C Agostini; M Facco; F Piazza; A Perin; M Siviero; C Gurrieri; S Galvan; F Adami; R Zambello; G Semenzato
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

8.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

9.  The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis.

Authors:  Mingzhi Han; Shunzeng Lv; Ya Zhang; Ruiyang Yi; Bin Huang; Hanhui Fu; Ruixiang Bian; Xingang Li
Journal:  Tumour Biol       Date:  2014-01-25

10.  Detrimental role of CC chemokine receptor 4 in murine polymicrobial sepsis.

Authors:  Tobias Traeger; Wolfram Kessler; Volker Assfalg; Katharina Cziupka; Pia Koerner; Constanze Dassow; Katrin Breitbach; Marlene Mikulcak; Ivo Steinmetz; Klaus Pfeffer; Claus-Dieter Heidecke; Stefan Maier
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.